Explore Trades
All Companies

ABBV

ABBVIE INC.

Pharmaceutical Preparations

$263.96updated Sep 19, 2026

Congressional trading profile for ABBVIE INC. (ABBV), covering 37 disclosed transactions by 13 lawmakers.

AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.

Total Trades

37

Politicians Trading

13

Last Traded

Jun 2, 2026

Price history

Congressional Trades

PartyDemocratRepublican
ChamberHouseSenate
TypeBuySell✕
PoliticianNotifiedTradedTypeAmountChange
Josh GottheimerDJun 3, 2026May 5, 2026Sell$1,001 - $15,000+28.07%
Ro KhannaDMay 11, 2026Apr 13, 2026Sell$15,001 - $50,000+27.84%
Julie JohnsonDJan 15, 2026Dec 18, 2025Sell$1,001 - $15,000+18.46%
Julia LetlowRJan 13, 2026Dec 8, 2025Sell$1,001 - $15,000+18.30%
Julia LetlowRJan 13, 2026Jan 24, 2025Sell$1,001 - $15,000+55.00%
Julie JohnsonDDec 11, 2025Nov 13, 2025Sell$1,001 - $15,000+13.63%
Lisa C. McClainRNov 21, 2025Oct 31, 2025Sell$1,001 - $15,000+21.06%
Lisa C. McClainRNov 21, 2025Oct 30, 2025Sell$1,001 - $15,000+15.67%
John BoozmanRSep 12, 2025Aug 22, 2025Sell$1,001 - $15,000+25.34%
John BoozmanRSep 12, 2025Aug 11, 2025Sell$1,001 - $15,000+32.88%
Julie JohnsonDSep 11, 2025Aug 14, 2025Sell$1,001 - $15,000+28.96%
Ritchie TorresDAug 20, 2025Jul 11, 2025Sell$1,001 - $15,000+37.16%
Lisa C. McClainRAug 13, 2025Jul 22, 2025Sell$1,001 - $15,000+41.07%
Josh GottheimerDMay 14, 2025Apr 17, 2025Sell$1,001 - $15,000+52.59%
Jefferson ShreveRMay 8, 2025Apr 17, 2025Sell$50,001 - $100,000+52.59%
Robert BresnahanRMay 8, 2025Apr 8, 2025Sell$1,001 - $15,000+50.26%
Dwight EvansDApr 17, 2025Apr 3, 2025Sell$1,001 - $15,000+30.91%